X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs LUPIN LTD - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD LUPIN LTD STRIDES SHASUN LTD/
LUPIN LTD
 
P/E (TTM) x 13.3 20.1 66.1% View Chart
P/BV x 1.5 2.7 56.5% View Chart
Dividend Yield % 0.6 0.9 69.9%  

Financials

 STRIDES SHASUN LTD   LUPIN LTD
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
LUPIN LTD
Mar-17
STRIDES SHASUN LTD/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs1,2751,750 72.8%   
Low Rs9181,384 66.4%   
Sales per share (Unadj.) Rs389.6387.4 100.6%  
Earnings per share (Unadj.) Rs28.056.6 49.4%  
Cash flow per share (Unadj.) Rs48.976.8 63.6%  
Dividends per share (Unadj.) Rs4.507.50 60.0%  
Dividend yield (eoy) %0.40.5 85.7%  
Book value per share (Unadj.) Rs303.1298.9 101.4%  
Shares outstanding (eoy) m89.42451.58 19.8%   
Bonus/Rights/Conversions ESOPESOPS-  
Price / Sales ratio x2.84.0 69.6%   
Avg P/E ratio x39.227.7 141.7%  
P/CF ratio (eoy) x22.420.4 110.0%  
Price / Book Value ratio x3.65.2 69.0%  
Dividend payout %16.113.2 121.5%   
Avg Mkt Cap Rs m98,036707,513 13.9%   
No. of employees `0005.816.8 34.5%   
Total wages/salary Rs m5,88128,495 20.6%   
Avg. sales/employee Rs Th6,005.910,418.3 57.6%   
Avg. wages/employee Rs Th1,014.01,697.0 59.8%   
Avg. net profit/employee Rs Th431.21,523.0 28.3%   
INCOME DATA
Net Sales Rs m34,834174,943 19.9%  
Other income Rs m1,6861,065 158.3%   
Total revenues Rs m36,520176,008 20.7%   
Gross profit Rs m6,42844,931 14.3%  
Depreciation Rs m1,8729,122 20.5%   
Interest Rs m2,2691,525 148.8%   
Profit before tax Rs m3,97335,349 11.2%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m483 4.4%   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m4709,785 4.8%   
Profit after tax Rs m2,50125,575 9.8%  
Gross profit margin %18.525.7 71.8%  
Effective tax rate %11.827.7 42.7%   
Net profit margin %7.214.6 49.1%  
BALANCE SHEET DATA
Current assets Rs m38,165119,542 31.9%   
Current liabilities Rs m30,40261,206 49.7%   
Net working cap to sales %22.333.3 66.8%  
Current ratio x1.32.0 64.3%  
Inventory Days Days7776 101.8%  
Debtors Days Days10490 116.3%  
Net fixed assets Rs m37,639131,660 28.6%   
Share capital Rs m894903 99.0%   
"Free" reserves Rs m26,210134,073 19.5%   
Net worth Rs m27,105134,976 20.1%   
Long term debt Rs m16,37756,478 29.0%   
Total assets Rs m81,168266,073 30.5%  
Interest coverage x2.824.2 11.4%   
Debt to equity ratio x0.60.4 144.4%  
Sales to assets ratio x0.40.7 65.3%   
Return on assets %5.910.2 57.7%  
Return on equity %9.218.9 48.7%  
Return on capital %12.119.3 62.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m13,46581,885 16.4%   
Fx outflow Rs m4,07621,506 19.0%   
Net fx Rs m9,38960,378 15.6%   
CASH FLOW
From Operations Rs m2,88141,148 7.0%  
From Investments Rs m-7,051-25,287 27.9%  
From Financial Activity Rs m3,3824,332 78.1%  
Net Cashflow Rs m-78820,193 -3.9%  

Share Holding

Indian Promoters % 27.7 46.6 59.4%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 37.8 11.3 334.5%  
FIIs % 8.6 31.9 27.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 10.1 256.4%  
Shareholders   56,241 98,259 57.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   WYETH LTD  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  SHASUN PHARMA  PFIZER  

Compare STRIDES SHASUN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Firm; Software & FMCG Stocks Gain(Closing)

Indian share markets finished the trading session well above the dotted line, snapping a three-day falling streak amid firm Asian markets.

Related Views on News

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Feb 21, 2018 03:35 PM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 5-YR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS